@article{1406986394fd45a6a6a07e5cfcc2608a,
title = "Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)",
keywords = "chemotherapy, dose-dense rituximab, doxorubicin, elderly-patients, exposure, non-hodgkin-lymphoma, optimization, plus cyclophosphamide, response assessment, vincristine, RESPONSE ASSESSMENT, DOXORUBICIN, CHEMOTHERAPY, PLUS CYCLOPHOSPHAMIDE, DOSE-DENSE RITUXIMAB, VINCRISTINE, NON-HODGKIN-LYMPHOMA, OPTIMIZATION, ELDERLY-PATIENTS, EXPOSURE",
author = "P.J. Lugtenburg and P.D. Brown and {van der Holt}, B. and F.A. D'Amore and H.R. Koene and {de Jongh}, E. and R. Fijnheer and {van Esser}, J.W. and L.H. Bohmer and J.F. Pruijt and G.E. Verhoef and M. Hoogendoorn and M.Y. Bilgin and M. Nijland and {van der Burg-de Graauw}, N.C. and M. Oosterveld and K.S.G. Jie and T.S. Larsen and {van der Poel}, M.W. and M.B. Leijs and M.H. Silbermann and M.V. Kooy and A. Beeker and M.J. Kersten and J.K. Doorduijn and L.W. Tick and R.E. Brouwer and K.H. Lam and C.N. Burggraaff and {de Keizer}, B. and A.I. Arens and {de Jong}, D. and O.S. Hoekstra and J.M. Zijlstra-Baalbergen",
year = "2020",
month = oct,
day = "10",
doi = "10.1200/JCO.19.03418",
language = "English",
volume = "38",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "29",
}